Crossmark

Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views

Crossref DOI link: https://doi.org/10.1177/2168479018812778

Published Online: 2019-12-19

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mayer, Mark https://orcid.org/0000-0003-0929-1185
Canedo, Angelica

Dinh, Tam

Low, Madelyn

Ortiz, Ariel

Garay, Chloé
Funding

Funding for this research was provided by:

Eli Lilly and Company
License Information

Text and Data Mining valid from 2019-11-01
More Information

Article History

Received: 16 August 2018

Accepted: 18 October 2018

First Online: 19 December 2019